Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.5200 (-4.5%) ($5.5200 - $5.5200) on Tue. Mar. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.65% (three month average) | RSI | 35 | Latest Price | $5.5200(-4.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -2.7% a day on average for past five trading days. | Weekly Trend | ANPC declines -8.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) GLD(16%) VXX(14%) SLV(11%) GDX(9%) GDXJ(9%) | Factors Impacting ANPC price | ANPC will decline at least -4.325% in a week (0% probabilities). ONLN(-15%) XLY(-11%) MCHI(-11%) FXI(-10%) KWEB(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.325% (StdDev 8.65%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-13.27(-340.4%) | Resistance Level | $6.51 | 5 Day Moving Average | $5.82(-5.15%) | 10 Day Moving Average | $6.3(-12.38%) | 20 Day Moving Average | $6.51(-15.21%) | To recent high | -34.8% | To recent low | 0.2% | Market Cap | $47m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |